Rieke Ringlstetter

Rieke Ringlstetter

Auto-generated profile, based on publicly available information

Rieke Ringlstetter

Institut for Biometrics, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2023 in Psychiatry Research
Verified
Journal Article
Open access
Kirsten Müller-VahlKirsten Müller-Vahl
Kirsten Müller-Vahl
APAnna Pisarenko
Anna Pisarenko
NSNatalia Szejko
Natalia Szejko
MHMartina Haas
Martina Haas
CFCarolin Fremer
Carolin Fremer
AGAnika Großhennig
Anika Großhennig
Preliminary data suggest that cannabis-based medicines might be a promising new treatment for patients with Tourette syndrome (TS)/chronic tic disorders (CTD) resulting in an improvement of tics, comorbidities, and quality of life. This randomized, multicenter, placebo-controlled, phase IIIb study aimed to examine efficacy and safety of the cannabis extract nabiximols in adults with TS/CTD (n = 97, randomized 2:1 to nabiximols:placebo). The primary efficacy endpoint was defined as a tic reduction of ≥ 25% according to the Total Tic Score of the Yale Global Tic Severity Scale after 13 weeks of treatment. Although a much larger number of patients in the nabiximols compared to the placebo group (14/64 (21·9%) vs. 3/33 (9·1%)) met the responder criterion, superiority of nabiximols could formally not be demonstrated. In secondary analyses, substantial trends for improvements of tics, depression, and quality of life were observed. Additionally exploratory subgroup analyses revealed an improvement of tics in particular in males, patients with more severe tics, and patients with comorbid attention deficit/hyperactivity disorder suggesting that these subgroups may benefit better from treatment with cannabis-based medication. There were no relevant safety issues. Our data further support the role of cannabinoids in the treatment of patients with chronic tic disorders.

1 February 2024 in Stroke
Verified
Journal Article
Closed access
SJSvenja L. Jochmann
Svenja L. Jochmann
ESEsther M.W. Sievering
Esther M.W. Sievering
JEJohanna Ernst
Johanna Ernst
RRRieke Ringlstetter
Rieke Ringlstetter
AGAnika Grosshennig
Anika Grosshennig
GGGerrit M. Grosse
Gerrit M. Grosse
BACKGROUND: Many ischemic strokes are diagnosed as embolic strokes of undetermined source (ESUS). Recent evidence suggests that nonstenotic carotid plaque (nsCP) may be a substantial contributor to the risk for ESUS. We aimed to investigate the risk factor profile associated with nsCP in ESUS and defined stroke etiologies. METHODS: In this retrospective case-control study, we investigated consecutive patients with acute ischemic stroke due to ESUS, small-vessel disease, or cardioembolism proven by magnetic resonance imaging. The association of vascular risk factors age, arterial hypertension, diabetes, dyslipoproteinemia, body mass index, alcohol consumption, tobacco use, kidney failure, and history of stroke with the presence of nsCP was investigated using binary logistic regression analysis and further stratified by stroke etiology and sex. RESULTS: In total, 609 patients (median age, 76 years; 46% women) who were treated from 2018 to 2020 were considered. In patients with ESUS, sex played a more important role for the prevalence of nsCP than in defined etiologies. Female patients with ESUS had lower odds of exhibiting nsCP compared with male patients with ESUS (adjusted odds ratio, 0.36 [95% CI, 0.15–0.86]). In male patients with ESUS, we observed that age (adjusted odds ratio per 10-year increase, 2.55 [95% CI, 1.26–5.17]) and hypertension (adjusted odds ratio, 2.49 [95% CI, 0.56–11.1]) were the main risk factors for nsCP, whereas in female patients with ESUS also tobacco use was particularly relevant (adjusted odds ratio, 3.71 [95% CI, 0.61–22.5]). These results were in line with a sensitivity analysis in nsCP located ipsilateral to the infarct. CONCLUSIONS: Sex differences play an important role in nsCP prevalence in patients with ESUS. These findings may have important implications for the management in targeted secondary prevention following ESUS.

28 May 2026 in European Journal of Pediatrics
Verified
Journal Article
Open access
ARAlexandros Rahn
Alexandros Rahn
SPSabine Pirr
Sabine Pirr
CPCorinna Peter
Corinna Peter
CBCarolin Böhne
Carolin Böhne
LKLara Klischke
Lara Klischke
TMThomas Müller
Thomas Müller
Accurate ultrasound assessment of abdominal organ size in preterm infants is essential for evaluating growth and detecting abnormalities. However, standardized reference intervals for liver, spleen, and kidney dimensions in preterms below 40 cm body length are lacking. This study aimed to establish reference intervals for these organs. 57 eutrophic preterm infants with a body length below 40 cm (gestational age: 23 4 / 7 —31 5 / 7 weeks; birth length: 29—39.5 cm) were prospectively examined using a standardized ultrasound protocol recommended by the German Society for Ultrasound in Medicine (DEGUM). Craniocaudal liver length, spleen length, and renal volume were measured and correlated with corrected gestational age, body weight, and body length. Reference intervals were calculated from log-transformed data with 95% confidence intervals for reference limits. Portal vein peak velocity before feeding and presence of a patent ductus venosus (PDV) were additionally assessed. Organ dimensions correlated most closely with body weight, followed by body length and corrected gestational age, with renal volume showing the highest correlations overall. Reference intervals for liver, spleen, and renal size showed tight 95% confidence intervals. Portal vein peak velocity ranged from 9—29 cm/s. A PDV was present in 56%; these infants were younger at examination (10.9 vs. 17 days, p = 0.01). Conclusion : This study provides clinically relevant ultrasound reference intervals for abdominal organs in small preterm infants. These measurements may help distinguish physiological from pathological findings and guide clinical decision-making in neonatal care. What is Known: • Ultrasound is the preferred imaging modality for abdominal organ assessment in preterm infants, but standardized sonographic reference intervals for infants with a body length below 40 cm are lacking. What is New: • This study provides the first standardized sonographic reference intervals for liver length, splenic length, and renal volume in preterm infants below 40 cm body length, using a prospective, reproducible protocol aligned with DEGUM recommendations. • Organ size correlated most strongly with body weight, followed by body length and corrected gestational age, with renal volume showing the highest overall correlations across all parameters.